Oct 15 (Reuters) – Kdventures AB: * PORTFOLIO COMPANY MODUS THERAPEUTICS TEMPORARILY PAUSES ENROLLMENT IN PHASE 2A STUDY OF SEVUPARIN IN CHRONIC KIDNEY DISEASE WITH ANEMIA * PAUSE IS NOT RESULT OF A
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Hyundai to recall over 94,600 US vehicles over fire risk from overheating, NHTSA says
Oct 15 (Reuters) - Hyundai Motor America is recalling 94,622 vehicles in the US over…
Entain gaming revenue rises 2% as domestic growth offsets hit from Brazil
Oct 15 (Reuters) - Ladbrokes owner Entain reported a 2% rise in third-quarter net gaming…
Taiwan president calls for Micron, workers to negotiate 'sincerely' ahead of possible strike
By Yi-Chin Lee and Ann Wang TAICHUNG, Taiwan Oct 15 (Reuters) - Taiwanese President Lai…
